<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03333902</url>
  </required_header>
  <id_info>
    <org_study_id>[2016]123</org_study_id>
    <nct_id>NCT03333902</nct_id>
  </id_info>
  <brief_title>The Comparison Of Nerve Blocks In Cesarean Delivery</brief_title>
  <official_title>The Comparison Of Different Nerve Blocks For Postoperative Analgesia In Cesarean Delivery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Feng Xia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of different kinds of popular
      peripheral nerve blocks for postoperative analgesia after cesarean delivery is completed,
      compared with traditional epidual analgesia..
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Actual">December 10, 2017</completion_date>
  <primary_completion_date type="Actual">November 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the change trend of visual analogue score (VAS) at rest and movement</measure>
    <time_frame>0-48 hours postoperatively</time_frame>
    <description>The purpose is to view the change of the level of pain assessed by subjects at adjacent time points. We would set 0, 4, 6, 12, 24, 48 hour postoperatively as observational time points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>total morphine consumption</measure>
    <time_frame>0-48hr postoperatively</time_frame>
    <description>extra need of analgesic (except the epidural group)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>0-48hr postoperatively</time_frame>
    <description>nausea, vomiting, retention of urine, lower limb weakness, etc.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Anesthesia, Obstetrical</condition>
  <arm_group>
    <arm_group_label>QLB type 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided, Inject at the point posterior to quadratus lumborum muscle, 0.2% ropivacaine 30mL in each side for a total of 60mL.
Subjects also receive an intravenous patient-controlled analgesia pump of 0.5mg/mL morphine for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>QLB type 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided, Inject at the point between the quadratus lumborum and the psoas major muscle, 0.2% ropivacaine 30mL in each side for a total of 60mL.
Subjects also receive an intravenous patient-controlled analgesia pump of 0.5mg/mL morphine for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>QLB type 2+3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided, conduct both QLB type 2 and 3, 0.2% ropivacaine 15mL in each point of injection, for a total of 60mL.
Subjects also receive an intravenous patient-controlled analgesia pump of 0.5mg/mL morphine for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided, inject at the point between the transversus abdominis and internal oblique muscle from lateral side, 0.2% ropivacaine 30mL in each side for a total of 60mL.
Subjects also receive an intravenous patient-controlled analgesia pump of 0.5mg/mL morphine for 48 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An epidural catheter was placed when finishing spinal anesthesia. After surgery we used a single bolus of 0.15% ropivacaine + 2 mg morphine (diluted in 6ml saline) via epidural cathether.
Subjects also receive an intravenous patient-controlled analgesia pump of 0.5mg/mL morphine for 48 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>QLB, TAP block</intervention_name>
    <description>QLB, quadratus lumborum block. TAP block, transversus abdominis plane block</description>
    <arm_group_label>QLB type 2</arm_group_label>
    <arm_group_label>QLB type 3</arm_group_label>
    <arm_group_label>QLB type 2+3</arm_group_label>
    <arm_group_label>TAP block</arm_group_label>
    <arm_group_label>epidural</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) physical status I or II

          -  weight from 50 to 70 kilogrammes

          -  a normal singleton pregnancy

          -  â‰¥37 weeks gestation

        Exclusion Criteria:

          -  congenital coagulopathy

          -  anatomic abnormalities

          -  localized skin infection

          -  allergy to any of the drugs used
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Subjects undergo cesarean delivery</gender_description>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun Yat-Sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.</citation>
    <PMID>26225500</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2017</study_first_submitted>
  <study_first_submitted_qc>November 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2017</study_first_posted>
  <last_update_submitted>April 8, 2018</last_update_submitted>
  <last_update_submitted_qc>April 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Feng Xia</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>quadratus lumborum block</keyword>
  <keyword>transversus abdominis plane block</keyword>
  <keyword>anesthesia</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

